Business

ACW XanaMIA Alzheimers open label trial commences

ACW XanaMIA Alzheimers open label trial commences

Actinogen Medical LimitedMarch 31, 20265
ACW XanaMIA Alzheimers open label trial commences

About this update from Actinogen Medical Limited

Actinogen Medical Ltd has released a press release. View Attachment

View stock analysis, news, and events for Actinogen Medical Limited

More from Actinogen Medical Limited

ACW unlisted options fully underwritten

August 31, 2026

ACW FY2026 results and outlook

August 27, 2026

All Actinogen Medical Limited news →